Abstract
CD44 is a widely distributed cell surface glycoprotein whose principal ligand has been identified as hyaluronic acid (HA), a major component of the extracellular matrix (ECM). Recent studies have demonstrated that activation through CD44 leads to induction of effector function in T cells and macrophages. At sites of chronic inflammation as seen in certain infections, autoimmune diseases, allograft rejection, graft-versus-host (GVH) disease and treatment of cancer patients with high doses of interleukin-2, significant damage to the endothelial cells has been known to occur, which leads to the toxicity or pathogenesis associated with the disease. The exact mechanism of endothelial cell damage is not clear, although, it has been widely speculated that immune cells may play a critical role. Studies from our laboratory have used interleukin-2 (IL-2) induced vascular leak syndrome (VLS) as a model to investigate the role of cytolytic lymphocytes in the direct cytotoxicity of endothelial cells. Cytotoxic T lymphocytes (CTL), double-negative (DN) T cells and natural killer (NK) cells upon activation express high levels of CD44 and mediate efficient MHC-unrestricted TCR-independent lysis following ligation of CD44. Such CD44-mediated cy...Continue Reading
Citations
Nov 20, 2002·Journal of Immunotherapy·Amjad MustafaMitzi Nagarkatti
May 22, 2004·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Sarah L SagueChristopher A Hunter
Oct 16, 2009·European Journal of Immunology·Benjamin KrämerJacob Nattermann
May 10, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hongbing GuanMitzi Nagarkatti
Oct 9, 2001·Journal of Neuropathology and Experimental Neurology·M ItoJ M Powers
Jan 26, 2005·American Journal of Reproductive Immunology : AJRI·Xuemei XieB Anne Croy
Apr 5, 2008·Journal of Leukocyte Biology·Venkatesh L HegdeMitzi Nagarkatti
Sep 9, 2011·Cancer Immunology, Immunotherapy : CII·Jingping SunRobert J McKallip
Nov 10, 2015·Mediators of Inflammation·Kohei KotaniSusumu Shiomi
Oct 20, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Clarissa SabellaXavier Fernàndez-Busquets
Jun 23, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hongbing GuanMitzi Nagarkatti
Mar 26, 2010·Journal of Biomedical Materials Research. Part a·Daniel B LyleJohn J Langone
Aug 9, 2003·The Journal of Biological Chemistry·Robert J McKallipMitzi Nagarkatti
May 8, 1999·Journal of the American Society of Nephrology : JASN·A KnoflachM H Sayegh